We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Noninvasive Laser Therapy for Stroke Treatment Could Help Avoid Surgical Removal of Blood Clot

By HospiMedica International staff writers
Posted on 20 Jun 2024
Print article
Image: Noninvasive laser therapy could be an effective new treatment for stroke patients (Photo courtesy of Stroke DOI: 10.1161/STROKEAHA.123.045358)
Image: Noninvasive laser therapy could be an effective new treatment for stroke patients (Photo courtesy of Stroke DOI: 10.1161/STROKEAHA.123.045358)

Individuals suffering from stroke currently have limited treatment options, generally involving a combination of intravenous thrombolysis and endovascular thrombectomy—methods involving the injection of clot-busting drugs and the mechanical removal of blood clots. However, these treatments are only effective within a specific timeframe and are suitable for only a subset of patients. Now, new research has revealed the potential for non-invasive light treatment for stroke utilizing lasers.

The approach targets endothelial cells, which line the blood vessels and play a pivotal role in the onset of stroke due to their dysfunction, marked by reduced production of nitric oxide (NO). NO is essential for keeping blood vessels open to ensure free blood flow. Building on prior findings that laser therapy can enhance NO production in these cells, researchers from Massachusetts General Hospital (Boston, MA, USA) explored the impact of laser therapy in a mouse stroke model.

Their findings indicate that applying low-power, invisible laser light to the head can significantly enhance brain blood flow and reduce stroke-related damage. The mechanism appears to involve laser treatment boosting NO production, which in turn improves blood vessel function in the brain. Given the established safety record of laser treatments for other medical conditions, there is optimism about the feasibility of testing this method in human trials soon. Additionally, laser therapy holds promise for treating a variety of other cardiovascular diseases linked to NO deficiencies.

“Unlike other approaches using chemicals, which can be toxic to our bodies, laser light is a physical parameter. It does not stay in the body after the therapy and will have little chance of causing side effects,” said co-senior author Satoshi Kashiwagi, MD, PhD, an investigator in the Department of Radiology at Massachusetts General Hospital. “We discovered a new way to effectively treat stroke using laser light, a modality that is already widely used in the clinic for procedures such as Lasik eye surgery and tattoo removal, and has a well-known safety profile. Thus, we expect that we could advance this technology to clinical trials relatively soon. Such technology has the potential to replace the current standard therapy using chemicals, which may cause side effects.”

Related Links:
Massachusetts General Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Auditory Evoked Potential Device
Bio-logic NavPRO ONE
New
Pediatric Phlebotomy Chair
2665M2 Extra Wide Pediatric Phlebotomy Chair

Print article

Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.